Amphora Discovery
closedOffers precision pathway-based drug discovery services, developing proprietary compounds for oncology and inflammation.
Launch date
Employees
Durham North Carolina (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$35.0m | Series A | ||
$12.5m | Series B | ||
$12.9m | Series B | ||
$20.0m | Series C | ||
$9.6m | Series D | ||
$4.4m | Series E | ||
Total Funding | $94.3m |